Impact of probiotics use on clinical outcomes of immune checkpoint inhibitors therapy in cancer patients

Impact of probiotics use on clinical outcomes of immune checkpoint inhibitors therapy in cancer patients

Abstract Background Dysbiosis of the gut microbiota can lead to impaired therapeutic effect of immune checkpoint inhibitors (ICIs). This study aimed to investigate the use of probiotics on the clinical outcomes of cancer patients receiving ICIs therapy. Method PubMed, EMBASE, and the Cochrane Librar...

Full description

Bibliographic Details
Main Authors: Luying Wan, Chunlan Wu, Qin Wu, Shuimei Luo, Junjin Liu, Xianhe Xie
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Cancer Medicine
Subjects:
gut microbiome
immune checkpoint inhibitors
objective response rate
overall survival
progression‐free survival
probiotics
Online Access:https://doi.org/10.1002/cam4.4994

Similar Items

Similar Items